Title: Introduction to Anti-Human CD143/ACE Antibody (SAA2704)
Anti-Human CD143/ACE Antibody (SAA2704) is a highly specific and sensitive monoclonal antibody that targets the human CD143/ACE protein. This antibody has been extensively studied and has shown promising results in various research areas, including cardiovascular diseases, cancer, and respiratory diseases. In this article, we will discuss the structure, activity, and applications of Anti-Human CD143/ACE Antibody (SAA2704) in detail.
Structure of Anti-Human CD143/ACE Antibody (SAA2704)
Anti-Human CD143/ACE Antibody (SAA2704) is a mouse monoclonal antibody that binds specifically to the human CD143/ACE protein. It is composed of two heavy chains and two light chains, which are connected by disulfide bonds. The antibody has a molecular weight of approximately 150 kDa and is composed of 1,332 amino acids. The variable region of the antibody is responsible for binding to the CD143/ACE protein, while the constant region is involved in effector functions.
Activity of Anti-Human CD143/ACE Antibody (SAA2704)
Anti-Human CD143/ACE Antibody (SAA2704) binds specifically to the human CD143/ACE protein, which is a membrane-bound enzyme that plays a crucial role in the renin-angiotensin-aldosterone system (RAAS). This system is responsible for regulating blood pressure and electrolyte balance in the body. CD143/ACE is also involved in the production of angiotensin II, a potent vasoconstrictor that can lead to hypertension and other cardiovascular diseases.
By binding to CD143/ACE, Anti-Human CD143/ACE Antibody (SAA2704) inhibits its activity, thereby reducing the production of angiotensin II. This leads to a decrease in blood pressure and can potentially prevent or treat cardiovascular diseases. Additionally, CD143/ACE is also expressed on the surface of certain cancer cells, and by targeting this protein, Anti-Human CD143/ACE Antibody (SAA2704) can potentially inhibit cancer cell growth and metastasis.
Applications of Anti-Human CD143/ACE Antibody (SAA2704)
Anti-Human CD143/ACE Antibody (SAA2704) has a wide range of applications in various research areas. Some of the key applications of this antibody include:
1. Cardiovascular diseases: As mentioned earlier, CD143/ACE plays a crucial role in the development of cardiovascular diseases. By targeting this protein, Anti-Human CD143/ACE Antibody (SAA2704) can potentially prevent or treat conditions such as hypertension, heart failure, and atherosclerosis.
2. Cancer research: CD143/ACE is overexpressed on the surface of certain cancer cells, making it a potential target for cancer therapy. Anti-Human CD143/ACE Antibody (SAA2704) has shown promising results in inhibiting the growth and metastasis of cancer cells, making it a valuable tool for cancer research.
3. Respiratory diseases: CD143/ACE is also expressed in the lungs and is involved in the development of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Anti-Human CD143/ACE Antibody (SAA2704) has shown potential in reducing inflammation and improving lung function in these conditions.
4. Drug development: Anti-Human CD143/ACE Antibody (SAA2704) can also be used in drug development as a tool to study the effects of CD143/ACE inhibition. This can help in the development of new and more effective drugs for various diseases.
Conclusion
Anti-Human CD143/ACE Antibody (SAA2704) is a highly specific and sensitive monoclonal antibody that targets the human CD143/ACE protein. It has a well-defined structure and inhibits the activity of CD143/ACE, making it a valuable tool in various research areas. Its potential applications in cardiovascular diseases, cancer, respiratory diseases,
There are no reviews yet.